# Efficacy and safety of orforglipron in adults with body mass index of 27 to less than 30 kg/m2 and adiposity-related complications: A post hoc analysis of the ATTAIN-1 trial

Article · Almandoz J, Miras A, Blüher M, Orozco Del Pino P, Mojdami D, Batterham R, Trice K, Goebel B, Tangi F

- Archive id: pmc:PMC13697276
- Published: 2026-10-14
- Venue: Obesity pillars
- PMCID: PMC13697276
- Citations: 0
- Source URL: https://europepmc.org/article/PMC/PMC13697276
- PDF: https://europepmc.org/articles/PMC13697276/pdf
- Provenance: europepmc

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.